Earnings Beats

NetApp, Inc. (NASDAQ: NTAP) has introduced new capabilities to bolster VMware Cloud Foundation deployments. These enhancements will allow mutual customers to optimize their IT environments for efficient scaling of VMware workloads. These offerings are built on last month's enhancements to...

Victoria's Secret & Co. (NYSE: VSCO) posted decent second-quarter fiscal 2024 results, with the top and the bottom line surpassing the Zacks Consensus Estimate. Earnings beat the consensus estimate for the third straight quarter. Victoria's Secret posted positive business trends in...

Nutanix (NASDAQ: NTNX) reported fourth-quarter fiscal 2024 non-GAAP earnings of 27 cents per share, which surpassed the Zacks Consensus Estimate by 35% and increased 12.5% year over year. Nutanix's revenues climbed 11% year over year to $548 million, beating the Zacks Consensus Estimate by 2.02...

Phibro Animal Health (NASDAQ: PAHC) delivered adjusted earnings per share of 41 cents in the fourth quarter of fiscal 2024, up 7.9% from the year-ago quarter's level. The bottom line beat the Zacks Consensus Estimate by 20.6%. Without adjustments, the GAAP EPS in the quarter was 2 cents,...

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) reported non-GAAP earnings of $1.04 per share in the second quarter of fiscal 2025, which surpassed the Zacks Consensus Estimate of 98 cents and came ahead of management's guidance of 98-99 cents. CRWD reported non-GAAP earnings of 74 cents in the year-...

Campbell Soup (NASDAQ: CPB) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.50 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings...

Affirm Holdings Inc (NASDAQ:AFRM) shares climbed Thursday after the company reported strong fourth-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. JPMorgan on Affirm Holdings Analyst Reginald Smith reiterated an Overweight...

Shares of Okta Inc (NASDAQ:OKTA) tanked in early trading on Thursday, even after the company reported upbeat second-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. DA Davidson analyst Rudy Kessinger reaffirmed a Neutral...

Nvidia Corp. (NASDAQ:NVDA) outperformed expectations, with impressive second-quarter earnings that beat forecasts. The AI computing giant credited its soaring revenue to robust data center performance, although its gross margin showed a slight contraction from the previous quarter. Nvidia also...

Shares of Salesforce Inc (NYSE:CRM) climbed in early trading on Thursday before sliding on the heels of an upbeat second-quarter financial report. Here are some key analyst takeaways. Check out other analyst stock ratings. Goldman Sachs analyst Kash Rangan maintained a Buy rating, while lifting the...

A month has gone by since the last earnings report for Flowserve (NYSE: FLS). Shares have lost about 0.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Flowserve due for a breakout? Before we dive into how...

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and Methodist Jennie Edmundson Hospital recently conducted a groundbreaking ceremony for a cutting-edge behavioral health hospital in Council Bluffs, IA. Plans to establish the hospital were announced in July 2023 as part of the joint-venture...

Illumina, Inc. (NASDAQ: ILMN) has secured the FDA's approval for its in vitro diagnostic (IVD) TruSight Oncology Comprehensive test and first two companion diagnostic (CDx) indications. The test analyses more than 500 genes to profile a patient's solid tumor, improving the chances...

Tenet Healthcare Corporation (NYSE: THC) shares have returned 24.6% in the past three months, outperforming both the hospital industry and the S&P 500 Index. Over this timeframe, the industry and the S&P 500 Indexhave gained 20.8% and 6.4%, respectively.  Currently priced at $163.87,...

Neogen's (NASDAQ: NEOG) vast international trade is impacted by global macroeconomic issues. Also, a tough competitive landscape weighs on the stock. NEOG stock carries a Zacks Rank #4 (Sell). Neogen's international business continues to be affected by currency movements. The current...